Structural analysis of ciprofloxacin-carbopol polymeric composites by X-ray diffraction and fourier transform infra-red spectroscopy

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 3, 2011, Pages 273-280

  Sahoo, S ^a   Chakraborti, C K ^a   Naik, S ^a   Mishra, S C ^b   Nanda, U N ^c  

^a Kanak Manjari Institute of Pharmaceutical Sciences   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^c SEEMANTA INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Carbopol; Ciprofloxacin; Fourier transform infrared; Polymeric composites; X ray diffraction

Indexed keywords

CARBOPOL 934; CARBOPOL 940; CIPROFLOXACIN; POLYMER; WATER;

ARTICLE; CRYSTALLIZATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; ESTERIFICATION; HYDROGEN BOND; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; POLYMERIZATION; POWDER DIFFRACTION; STRUCTURE ANALYSIS; SUSTAINED DRUG RELEASE; X RAY DIFFRACTION;

EID: 79959994475     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v10i3.14     Document Type: Article

References (20)

1. Schlogl R. X-ray Diffraction: A Basic Tool for Characterization of Solid Catalysts in the Working State. Adv Catal 2009; 52: 273-338.
2. Fucke K, Steed JW. X-Ray and Neutron Diffraction in the Study of Organic Crystalline Hydrates. Water 2010; 2: 333-350.
3. Thangadurai S, Shukla SK, Srivastava AK, Anjaneyulu Y. X-ray powder diffraction patterns for certain fluoroquinolone antibiotic drugs. Acta Pharm 2003; 53: 295-303.
4. Murthy NS. Recent Developments in polymer Characterization using X-Ray Diffraction. The Rigaku Journal 2004; 21(1): 15-24.
5. Choi WS, Kwak SS, Kim HI. Improvement of bioavailability of water insoluble drugs: potential of nano-sized grinding technique. Asian J Pharm Sci 2006; 1(1): 27-30.
6. Choudhary D, Kumar S, Gupta GD. Enhancement of solubility and dissolution of glipizide by solid dispersion (kneading) technique. Asian J Pharmaceutics 2009; 3(3): 245-251.
7. Keraliya RA, Soni TG, Thakkar VT, Gandhi TR. Formulation and Physical characterization of microcrystals for dissolution rate enhancement of Tolbutamide. Int J Res Pharm Sci 2010; 1(1): 69-77.
8. Chang DL, Jasmine EH, Pollock-Dove C, Patrick SLW 2006, (WO/2006/007354) A Drug/Polymer Complex, Preferably Ciprofloxacin/HPMC, Its Method of Manufacturing Using Lyophilisation and Its use in an Osmotic Device; [cited 2010 Jan 13]. Available from: http://www.wipo.int/pctdb/en/wo.jsp?WO=2006007354&IA=US2005020356&DISPLAY=DESC.
9. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Delivery Rev 2001; 53(3): 321-339.
10. Bettini R, Colombo P, Peppas NA. Solubility effects on drug transport through pH-sensitive, swelling-controlled release systems: Transport of theophylline and metoclopramide monohydrochloride. J Controlled Release 1995; 37(1-2): 105-111.
11. Hosmani AH. Carbopol and its Pharmaceutical Significance: A Review; [cited 2010 Jan 20]. Available from: http://www.pharmainfo.net/reviews/carbopol-and-its-pharmaceuticalsignificance-review.
12. Cruz AP, Rodrigues PO, Cardoso TM, Silva MAS. Mechanical and Imaging Studies of Hydrophilic Matrices formed by Polymeric Blends of HPMC and Carbopol. Am J Pharm 2007; 26 (2): 171-178.
13. Galaev IY, Mattiasso B. 'Smart' polymers and what they could do in biotechnology and medicine. Trends Biotechnol 1999; 17(8): 335-340.
14. Jeong B, Gutowska A. 2001 Stimuli-responsive polymers and their biomedical applications. Trends Biotechnol 2001; 20: 305-311.
15. Guo JH. Carbopol® Polymers for Pharmaceutical Drug Delivery Applications Drug Delivery Technology; [cited 2010 Oct 9]. Available from: http://www.drugdeliverytech.com/ME2/dirmod.asp?sid=4306B1E9C3CC4E07A4D64E23FBDB232C&nm=Back+Issues&type=Publishing&mod=Publications%3A%3AArticle&mid=8F3A7027421841978F18BE895F87F791&tier=2&did=9A6084AE4264441A9EC178DC96951FDC&dtxt=Vol%2E+3+No%2E+6+September+2003.
16. Florence AJ, Kennedy AR, Shankland N, Wright E, Al-Rubayi A. Norfloxacin dehydrate. Acta Cryst 2000; 56: 1372-1373.
17. Dani VR. Organic Spectroscopy. Tata McGraw-Hill Publishing Company Limited, New Delhi, 1995; pp 86-168.
18. Tom RT, Suryanarayana V, Reddy PG, Baskaran S, Pradeep T. Ciprofloxacin protected gold nanoparticles. Langmuir 2004; 20(5): 1909-1914.
19. Silverstein RM, Webster FX. Spectrometric identification of Organic Compounds. John Wiley & Sons, New York, 2002; pp 71-109.
20. Garrido NJ, Perello L, Ortiz R, Alzuet G, Alvarez MG, Canton E, Gonzalez ML, Granda SG, Priede MP. Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin. J Inorg Biochem 2005; 99: 677-689.